Browse studies

Find your next paid study

1 recruiting study matching your filters

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Randomized phase 2, multicenter, biomarker directed clinical trial with a safety lead-in to assess the efficacy of Stenoparib plus Temozolomide (TMZ) in relaps…

Relapsed Small Cell Lung CancerRecurrent Small Cell Lung Cancer

VA Office of Research and DevelopmentNCT06681220